Also trades as: RAY-B.ST (STO) · $vol 3M
RSLBF OTC
RaySearch Laboratories AB (publ)
1W: +0.0%
1M: -16.7%
3M: -22.1%
YTD: -30.7%
1Y: -40.2%
3Y: +161.9%
5Y: +120.3%
$16.50
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1.3B
+12.8% ▲
5Y CAGR: +15.6%
Gross Profit
$1.2B
+13.7% ▲
5Y CAGR: +15.4%
Operating Income
$292M
+12.2% ▲
Net Income
$228M
+11.9% ▲
EPS (Diluted)
$6.65
+12.0% ▲
EBITDA
$292M
-48.8% ▼
5Y CAGR: +31.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $642M | $844M | $1.0B | $1.2B | $1.3B |
| YoY Growth | -1.5% | +31.5% | +21.2% | +16.6% | +12.8% |
| Cost of Revenue | $50M | $95M | $107M | $99M | $102M |
| Gross Profit | $591M | $749M | $916M | $1.1B | $1.2B |
| Gross Margin | 92.1% | 88.7% | 89.6% | 91.7% | 92.4% |
| R&D Expenses | $233M | $239M | $238M | $269M | $270M |
| SG&A Expenses | $422M | $481M | $558M | $576M | $650M |
| Operating Expenses | $655M | $718M | $801M | $832M | $950M |
| Operating Income | -$53M | $43M | $115M | $260M | $292M |
| Operating Margin | -8.2% | 5.1% | 11.2% | 21.9% | 21.7% |
| Interest Expense | $6M | $11M | $10M | $9M | $0 |
| Income Before Tax | -$59M | $32M | $110M | $263M | $288M |
| Tax Expense | -$11M | $9M | $29M | $59M | $60M |
| Net Income | -$47M | $24M | $82M | $204M | $228M |
| Net Margin | -7.4% | 2.8% | 8.0% | 17.1% | 16.9% |
| EPS (Diluted) | $-1.38 | $0.69 | $2.38 | $5.94 | $6.65 |
| EBITDA | $197M | $341M | $406M | $571M | $292M |
| Shares Outstanding | 34M | 34M | 34M | 34M | 34M |